glp 1 microdosing side effects GLP-1 for autoimmune conditions: what the research actually shows People Are Microdosing Weight-Loss Drugs
Description
Red Flag Update Weight-Loss Illusion The risk at HIMS for investors who fail to grasp what's real
February 2, 2026: FDA Published Second Safety Label Change of 2026 for Zepbound Eli Lillys popular weight-loss drug Zepbound had a second safety label update in January 2026
Study that establishes the efficacy and safety of liraglutide in patients with T2DM and moderate renal impairment, but shows a lack of effect of acute and prolonged therapy with this GLP-1R agonist on eGFR trajectory compared to placebo
4 Recent studies in animal models have shown that GLP-2 also exerts beneficial effects on glucose homeostasis, 5,6 spontaneous hypertension 7,8,9 and depression
At 5mg/ml, you would need to split the 7.5mg dose into two separate injections since 150 units exceeds the capacity of a standard insulin syringe
The result is decreased appetite and reduced food consumption
